Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barij Nayan Sinha

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Scientia Pharmaceutica|March 18, 2014
Isolation and evaluation of the enantiospecific antitubercular activity of a novel triazole compoundRadha Shekar, Barij Nayan Sinha, Arindam Mukhopadhya, et al.
Mini Reviews in Medicinal Chemistry|November 1, 2021
A Critical Observation on the Design and Development of Reported Peptide Inhibitors of DENV NS2B-NS3 Protease in the Last Two DecadesSheikh Murtuja, Deepak Shilkar, Biswatrish Sarkar, et al.
Bioorganic & Medicinal Chemistry|October 3, 2021
A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteasesSheikh Murtuja, Deepak Shilkar, Biswatrish Sarkar, et al.
Natural Product Research|May 8, 2020
Two new anticancer phenolic derivatives from leaves of <i>Piper betle</i> LinnAkhtar Atiya, Mohammed Azhar Salim, Barij Nayan Sinha, et al.
European Journal of Medicinal Chemistry|October 22, 2008
Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening modelsS Vadivelan, Barij Nayan Sinha, Sunita Tajne, et al.
European Journal of Medicinal Chemistry|December 4, 2018
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1Mohd Usman Mohd Siddique, Tabassum Khair Barbhuiya, Barij Nayan Sinha, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and SynthesisVishnu Nayak Badavath, İpek Baysal, Gulberk Ucar, et al.
Journal of Chemical Information and Modeling|May 26, 2007
Virtual screening studies to design potent CDK2-cyclin A inhibitorsS Vadivelan, Barij Nayan Sinha, Sheeba Jem Irudayam, et al.
Acta Crystallographica. Section E, Crystallographic Communications|August 5, 2017
Crystal structures of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-<i>N</i>-(2,4-di-methyl-phen-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-<i>N</i>-(3-meth-oxy-phen-yl)acetamideManisha Choudhury, Vijayan Viswanathan, Ajay Kumar Timiri, et al.
Acta Crystallographica. Section E, Crystallographic Communications|June 1, 2018
Crystal structures and Hirshfeld surface analyses of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-<i>N</i>-(pyridin-2-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-<i>N</i>-(pyrazin-2-yl)acetamideManisha Choudhury, Vijayan Viswanathan, Ajay Kumar Timiri, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Scientia Pharmaceutica|March 18, 2014
Isolation and evaluation of the enantiospecific antitubercular activity of a novel triazole compoundRadha Shekar, Barij Nayan Sinha, Arindam Mukhopadhya, et al.
Mini Reviews in Medicinal Chemistry|November 1, 2021
A Critical Observation on the Design and Development of Reported Peptide Inhibitors of DENV NS2B-NS3 Protease in the Last Two DecadesSheikh Murtuja, Deepak Shilkar, Biswatrish Sarkar, et al.
Bioorganic & Medicinal Chemistry|October 3, 2021
A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteasesSheikh Murtuja, Deepak Shilkar, Biswatrish Sarkar, et al.
Natural Product Research|May 8, 2020
Two new anticancer phenolic derivatives from leaves of <i>Piper betle</i> LinnAkhtar Atiya, Mohammed Azhar Salim, Barij Nayan Sinha, et al.
European Journal of Medicinal Chemistry|October 22, 2008
Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening modelsS Vadivelan, Barij Nayan Sinha, Sunita Tajne, et al.
European Journal of Medicinal Chemistry|December 4, 2018
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1Mohd Usman Mohd Siddique, Tabassum Khair Barbhuiya, Barij Nayan Sinha, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and SynthesisVishnu Nayak Badavath, İpek Baysal, Gulberk Ucar, et al.
Journal of Chemical Information and Modeling|May 26, 2007
Virtual screening studies to design potent CDK2-cyclin A inhibitorsS Vadivelan, Barij Nayan Sinha, Sheeba Jem Irudayam, et al.
Acta Crystallographica. Section E, Crystallographic Communications|August 5, 2017
Crystal structures of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-<i>N</i>-(2,4-di-methyl-phen-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-<i>N</i>-(3-meth-oxy-phen-yl)acetamideManisha Choudhury, Vijayan Viswanathan, Ajay Kumar Timiri, et al.
Acta Crystallographica. Section E, Crystallographic Communications|June 1, 2018
Crystal structures and Hirshfeld surface analyses of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-<i>N</i>-(pyridin-2-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-<i>N</i>-(pyrazin-2-yl)acetamideManisha Choudhury, Vijayan Viswanathan, Ajay Kumar Timiri, et al.
Pageof 5